[Federal Register Volume 82, Number 44 (Wednesday, March 8, 2017)]
[Notices]
[Page 12968]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04529]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2017-N-0067]
Joint Meeting of the Drug Safety and Risk Management Advisory
Committee and the Anesthetic and Analgesic Drug Products Advisory
Committee; Amendment of Notice
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing an
amendment to the notice of the joint meeting of the Drug Safety and
Risk Management Advisory Committee and the Anesthetic and Analgesic
Drug Products Advisory Committee. This meeting was announced in the
Federal Register of January 11, 2017. The amendment is being made to
reflect a change in the ADDRESSES portion of the document. There are no
other changes.
FOR FURTHER INFORMATION CONTACT: Stephanie L. Begansky, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301-
796-9001, FAX: 301-847-8533, email: [email protected], or FDA Advisory
Committee Information Line, 1-800-741-8138 (301-443-0572 in the
Washington, DC area). Please call the Information Line for up-to-date
information on this meeting.
SUPPLEMENTARY INFORMATION: In the Federal Register of January 11, 2017
(82 FR 3333), FDA announced that the joint meeting of the Drug Safety
and Risk Management Advisory Committee and the Anesthetic and Analgesic
Drug Products Advisory Committee would be held on March 13-14, 2017. On
page 3334, in the first column, under the ADDRESSES caption, the
address of the meeting and the phone number in the first six lines is
changed to read as follows:
ADDRESSES: The meeting will be held at the Tommy Douglas Conference
Center, 10000 New Hampshire Ave., Silver Spring, MD 20903. The
conference center's telephone number is 240-645-4000.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.
Dated: March 3, 2017.
Janice M. Soreth,
Associate Commissioner for Special Medical Programs.
[FR Doc. 2017-04529 Filed 3-7-17; 8:45 am]
BILLING CODE 4164-01-P